CA3242987A1 - NEW VALPROIC ACID ANALOGUES AND MEDICAL TREATMENT METHODS USING THESE - Google Patents

NEW VALPROIC ACID ANALOGUES AND MEDICAL TREATMENT METHODS USING THESE

Info

Publication number
CA3242987A1
CA3242987A1 CA3242987A CA3242987A CA3242987A1 CA 3242987 A1 CA3242987 A1 CA 3242987A1 CA 3242987 A CA3242987 A CA 3242987A CA 3242987 A CA3242987 A CA 3242987A CA 3242987 A1 CA3242987 A1 CA 3242987A1
Authority
CA
Canada
Prior art keywords
methods
same
medical treatment
valproic acid
novel analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3242987A
Other languages
English (en)
French (fr)
Inventor
Tomas Fex
Jonas Faijerson Saljo
Original Assignee
Cereno Scientific AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cereno Scientific AB filed Critical Cereno Scientific AB
Publication of CA3242987A1 publication Critical patent/CA3242987A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3242987A 2021-12-20 2022-12-20 NEW VALPROIC ACID ANALOGUES AND MEDICAL TREATMENT METHODS USING THESE Pending CA3242987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2118559.0 2021-12-20
GB2118559.0A GB2613900B (en) 2021-12-20 2021-12-20 Novel compounds and methods of use thereof
PCT/GB2022/053318 WO2023118846A1 (en) 2021-12-20 2022-12-20 Novel analogs of valproic acid and methods of medical treatment using the same

Publications (1)

Publication Number Publication Date
CA3242987A1 true CA3242987A1 (en) 2023-06-29

Family

ID=84887257

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3242987A Pending CA3242987A1 (en) 2021-12-20 2022-12-20 NEW VALPROIC ACID ANALOGUES AND MEDICAL TREATMENT METHODS USING THESE

Country Status (11)

Country Link
US (1) US20250066282A1 (https=)
EP (1) EP4452917A1 (https=)
JP (1) JP2025500459A (https=)
KR (1) KR20240152301A (https=)
CN (1) CN118613464A (https=)
AU (1) AU2022422574A1 (https=)
CA (1) CA3242987A1 (https=)
GB (1) GB2613900B (https=)
IL (1) IL313669A (https=)
MX (1) MX2024007654A (https=)
WO (1) WO2023118846A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2644641A (en) * 2024-09-24 2026-04-29 Cereno Scient Ab New methods
WO2026068561A1 (en) 2024-09-24 2026-04-02 Cereno Scientific Ab Valproic acid for use in treating pulmonary arterial hypertension
GB2644610A (en) * 2024-09-27 2026-04-22 Cereno Scient Ab New methods
WO2026068552A1 (en) 2024-09-24 2026-04-02 Cereno Scientific Ab Deuterated valproic acid compounds for use in treating pulmonary arterial hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120071554A1 (en) * 2008-10-28 2012-03-22 Liu Julie F Deuterated 2-propylpentanoic acid compounds
US20100143507A1 (en) * 2008-12-09 2010-06-10 Auspex Pharmaceuticals, Inc. Carboxylic acid inhibitors of histone deacetylase, gaba transaminase and sodium channel
GB201417828D0 (en) * 2014-10-08 2014-11-19 Cereno Scient Ab New methods and compositions
RU2760304C2 (ru) * 2016-04-08 2021-11-23 Серено Сайентифик Аб Фармацевтические составы с отсроченным высвобождением, содержащие вальпроевую кислоту, и их применение

Also Published As

Publication number Publication date
GB2613900A (en) 2023-06-21
CN118613464A (zh) 2024-09-06
IL313669A (en) 2024-08-01
KR20240152301A (ko) 2024-10-21
MX2024007654A (es) 2024-07-04
GB2613900B (en) 2024-01-17
AU2022422574A1 (en) 2024-07-18
EP4452917A1 (en) 2024-10-30
US20250066282A1 (en) 2025-02-27
WO2023118846A1 (en) 2023-06-29
JP2025500459A (ja) 2025-01-09

Similar Documents

Publication Publication Date Title
CA3242987A1 (en) NEW VALPROIC ACID ANALOGUES AND MEDICAL TREATMENT METHODS USING THESE
JP2971053B2 (ja) ヒドロキサム酸誘導体の合成中間体
JPH10504821A (ja) 金属タンパク質分解酵素阻害剤
US6423690B1 (en) Antibacterial agents
EP0489579B1 (en) Peptidyl derivatives
DE69516143T2 (de) Metalloproteinase inhibitoren
JP3297053B2 (ja) 金属タンパク質分解酵素阻害剤
EA023500B1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
JPH11503746A (ja) サクシンアミド誘導体と金属タンパク質分解酵素阻害剤としてのその使用
US20080188565A1 (en) Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
EA202091773A1 (ru) Способ модуляции сигнальных путей tigit и pd-1 с применением 1,2,4-оксадиазольных соединений
CR20240183A (es) Inhibidores y/o degradadores de bckdk
HUP9904664A2 (hu) Mátrix metalloproteáz inhibitor hatású, helyettesített 4-bifenil-4-hidroxivajsav-származékok
US20170267632A1 (en) Methionine analogs and methods of using same
KR19980703485A (ko) 에폭시숙신산 유도체
JP2003519100A (ja) ベータ二置換メタロプロテアーゼ阻害剤
MA53683A1 (fr) Acide pyridyloxycarboxylique de type r, sel et dérivé ester de celui-ci, procédé de préparation correspondant, composition herbicide et utilisation associées
JP3250806B2 (ja) N−(メルカプトアシル)アミノ酸と、その製造方法と、その治療での使用と、それを含む医薬組成物
US20020068722A1 (en) Alpha-substituted thio,-oxo trifluoromethylketones as phospholipase inhibitors
RU2246941C2 (ru) Антибактериальные агенты
AU2002300119B2 (en) Antibacterial agents
JP2849810B2 (ja) ヒト免疫不全ウイルス(hiv)プロテアーゼ阻害化合物、その製造方法、及びそれを含む組成物
DK163300B (da) Analogifremgangsmaade til fremstilling af fluorerede alkandiaminderivater eller pharmaceutisk acceptable salte deraf
JP2016006043A (ja) 新規キノン誘導体およびそれを有効成分とする抗トリパノソーマ剤

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20240703

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20240703

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P104 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR PRIORITY RECEIVED

Effective date: 20240703

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20240703

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W00-W00-W005 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INACTIVE: FIRST IPC ASSIGNED

Effective date: 20240703

Free format text: ST27 STATUS EVENT CODE: A-1-1-W00-W00-W128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INACTIVE: IPC ASSIGNED

Effective date: 20240703

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20240703

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241202

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241202